ESTRONE SULFURIC ACID

SynDRA canonical compound SYN0016062 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ESR1 \| ESR2
Mechanism of action	estrogen receptor agonist
Indication	hypoestrogenism \| menopause \| osteoporosis \| osteoporosis, menopause, vaginal atrophy, hypoestrogenism \| vaginal atrophy
Disease area	endocrinology \| endocrinology \| obstetrics/gynecology \| orthopedics \| orthopedics, endocrinology, obstetrics/gynecology

All known targets

estrone sulphate
estrone sodium sulfate
estropipate
piperazine estrone sulfate
sodium estrone sulfate
Estrone sulphate
Estropipate
Piperazine estrone sulfate
Harmogen
Ogen
Ortho-Est
UNII-SVI38UY019
Piperazine estronesulfate
Sulestrex
SVI38UY019
Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1)
OGEN 2.5
Estropipate (USP)
OGEN 5
Ogen (TN)
OGEN .625
OGEN 1.25
EINECS 230-696-3
piperazine (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate
Piperazine oestrone sulphate
Conjugated estrogens: piperazine estrone sulfate
Estrone hydrogen sulf
Estrone Sulfate
Estrone hydrogen sulfate
ESTRONE 3 SULFATE
Estrone 3-sulphate
Estrone bisulfate
Estrone hemisulfate
Estrone, hydrogen sulfate
CONJUGOL
PRICE
QTL48N278K
CHEBI:17474
Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate